NASDAQ:NATR

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

$16.24
+0.62 (+3.97%)
(As of 03:15 PM ET)
Today's Range
$15.56
$16.47
50-Day Range
$15.62
$20.87
52-Week Range
$10.06
$21.72
Volume
76,599 shs
Average Volume
52,590 shs
Market Capitalization
$305.62 million
P/E Ratio
21.09
Dividend Yield
N/A
Price Target
$24.00

Nature's Sunshine Products MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
47.8% Upside
$24.00 Price Target
Short Interest
Healthy
0.50% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.16mentions of Nature
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.70 out of 5 stars

Medical Sector

330th out of 915 stocks

Pharmaceutical Preparations Industry

141st out of 426 stocks

NATR stock logo

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

NATR Stock Price History

NATR Stock News Headlines

Buy Friday. Sell Monday.
A 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.
7 Cheap and Good Stocks
It's the holy grail of the stock market... Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains. Well, we've uncovered SEVEN such stocks.
Nature's Sunshine: Q1 Earnings Snapshot
Why Nature's Sunshine (NATR) Stock Is Up Today
See More Headlines
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
5/10/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Current Symbol
NASDAQ:NATR
CUSIP
63902710
Employees
814
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.00
High Stock Price Target
$24.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+49.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$15.08 million
Pretax Margin
4.54%

Debt

Sales & Book Value

Annual Sales
$445.32 million
Cash Flow
$1.35 per share
Book Value
$8.36 per share

Miscellaneous

Free Float
17,897,000
Market Cap
$303.17 million
Optionable
Optionable
Beta
0.85
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Terrence O. Moorehead (Age 61)
    President, CEO & Director
    Comp: $2.12M
  • Mr. L. Shane Jones (Age 53)
    Executive VP, CFO & Treasurer
    Comp: $1.01M
  • Mr. Martin Gonzalez (Age 54)
    Executive Vice President of Global Supply Chain Operations
    Comp: $690.73k
  • Trent McCausland
    Executive Director, Head of Operations & COO
  • Mr. Nathan G. Brower (Age 43)
    Executive VP, General Counsel & Secretary
  • Ms. Sarah Crockett (Age 41)
    Global Chief Marketing Officer
  • Ms. Tracee Comstock (Age 58)
    Senior Vice President of Global Human Resources
  • Mr. Bryant J. Yates (Age 51)
    Executive VP & President of Europe
    Comp: $496.15k
  • Mr. Daniel C. Norman (Age 49)
    Executive VP & President of Asia/Pacific (APAC)
    Comp: $574.31k
  • Mr. Kevin R. Herbert (Age 57)
    Executive VP & President of North America

NATR Stock Analysis - Frequently Asked Questions

Should I buy or sell Nature's Sunshine Products stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NATR shares.
View NATR analyst ratings
or view top-rated stocks.

What is Nature's Sunshine Products' stock price target for 2024?

1 Wall Street analysts have issued 12-month price targets for Nature's Sunshine Products' shares. Their NATR share price targets range from $24.00 to $24.00. On average, they expect the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 47.8% from the stock's current price.
View analysts price targets for NATR
or view top-rated stocks among Wall Street analysts.

How have NATR shares performed in 2024?

Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR shares have decreased by 6.1% and is now trading at $16.24.
View the best growth stocks for 2024 here
.

Are investors shorting Nature's Sunshine Products?

Nature's Sunshine Products saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 73,700 shares, a decrease of 19.5% from the April 15th total of 91,600 shares. Based on an average trading volume of 57,000 shares, the short-interest ratio is presently 1.3 days. Approximately 0.5% of the shares of the stock are sold short.
View Nature's Sunshine Products' Short Interest
.

When is Nature's Sunshine Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our NATR earnings forecast
.

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its quarterly earnings results on Tuesday, March, 12th. The company reported $0.45 earnings per share (EPS) for the quarter. The firm earned $108.94 million during the quarter. Nature's Sunshine Products had a net margin of 3.39% and a trailing twelve-month return on equity of 12.25%.

Is Nature's Sunshine Products a good dividend stock?

Nature's Sunshine Products (NASDAQ:NATR) pays an annual dividend of $0.40 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 51.95%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NATR.

What guidance has Nature's Sunshine Products issued on next quarter's earnings?

Nature's Sunshine Products updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $467.9 million.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?

13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT).

Who are Nature's Sunshine Products' major shareholders?

Nature's Sunshine Products' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (2.75%), State Board of Administration of Florida Retirement System (0.38%), Janney Montgomery Scott LLC (0.13%), BNP Paribas Financial Markets (0.08%) and SG Americas Securities LLC (0.06%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap.
View institutional ownership trends
.

How do I buy shares of Nature's Sunshine Products?

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NATR) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners